Related Experiment Video
Updated: Jul 8, 2026

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Contrast-induced nephropathy: what are the true clinical consequences?
Michael Rudnick1, Harold Feldman
1Renal Electrolyte and Hypertension Division, Penn Presbyterian Medical Center, Philadelphia, Pennsylvania 19104, USA. rudnickm@uphs.upenn.edu
Contrast-induced nephropathy (CIN) is linked to increased patient mortality. While not definitively causal, reducing CIN incidence is crucial for patient outcomes and future research.
Area of Science:
- Nephrology
- Cardiology
- Radiology
Background:
- Observational studies indicate elevated mortality in patients with contrast-induced nephropathy (CIN).
- Key questions remain regarding the causal link between CIN and mortality.
- The potential for mortality reduction through CIN prevention requires investigation.
Purpose of the Study:
- To review the association between CIN and mortality.
- To explore the extent to which CIN prevention could reduce mortality in patients undergoing contrast procedures.
Main Methods:
- A comprehensive literature review was performed.
- Focus on observational studies examining mortality factors in CIN patients.
Main Results:
- Patient deaths in CIN cases are often multifactorial (e.g., sepsis, liver disease).
- CIN may plausibly contribute to cardiovascular mortality.
- CIN serves as a marker for heightened mortality risk.
Conclusions:
- A definitive causal relationship between CIN and mortality requires further investigation.
- Prospective studies are essential to clarify this relationship.
- Preventing CIN should remain a clinical and research priority.
Related Concept Videos
Diabetic Nephropathy
Chronic Kidney Disease II: Clinical Manifestations
Nephrotic Syndrome I : Introduction
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
